Zuckerberg: Data, Not Ads, Fueled Facebook's Growth
Mark Zuckerberg reveals Facebook's secret weapon was its data-driven Growth Team, not big ad budgets. Discover how product features like 'People You May Know' drove virality. Read more!
Category : Search result: pharma profit growth
Obesity Drug Market in India Grows 10-Fold in 5 Years
India's anti-obesity market, now valued at over Rs 1,000 crore, is poised for explosive growth with new drugs and generics. Discover how AI and GLP-1 therapies are transforming healthcare.
Orange Biotech PCD Pharma Franchise: Lucrative Business Opportunity
Orange Biotech Private Limited unveils a nationwide PCD pharma franchise with high-profit margins, monopoly rights, and extensive product portfolio for entrepreneurs. Start your own pharma business today!
Aurobindo Pharma increases stake in China JV to 50%
Aurobindo Pharma's Dutch arm buys 20% more in China's Luoxin Aurovitas for $5M, aiming for 100% ownership by 2029 to scale up inhalation product manufacturing. Read the full strategic move.
India Pharma Targets $500B, Innovation Hub by 2047
India's pharmaceutical industry gears up for a critical 5-year phase from 2026, aiming to become a $500 billion innovation hub by 2047. Learn how it plans to tackle challenges and seize opportunities.
India's GDP growth slows to 7.8% in Q4, FY24 at 8.2%
India's GDP growth moderated to 7.8% in the January-March quarter, bringing the full-year FY24 growth to a robust 8.2%. Key sectors show mixed performance as economists watch monsoon impact.
Parle Agro FY25 Profit Jumps Multi-fold to Rs 115 Crore
Parle Agro, maker of Frooti and Appy, reports a massive surge in consolidated net profit to Rs 115.38 crore for FY25. Revenue grew 5% to Rs 3,284 crore. Read the full financial breakdown here.
Bangladesh Beats India to Export Weight-Loss Drugs to Emerging Markets
Bangladesh's pharma firms have a 2-year head start over Indian giants like Dr Reddy's in exporting generic semaglutide. Delhi HC allows exports, but domestic sales wait until 2026. Explore the competitive landscape.
Nivin Pauly's 'Pharma' Trailer Targets Unethical Drug Practices
Nivin Pauly's OTT debut 'Pharma' trailer reveals a medical rep exposing dangerous drugs. The series premieres on JioCinema December 19 in 7 languages. Read more.
Laurus Labs aims for 50% revenue from CDMO business in 5 years
Hyderabad's Laurus Labs plans aggressive CDMO growth, targeting 50% of revenue in five years. CEO Dr. Satyanarayana Chava reveals strategy focusing on cell & gene therapy and global expansion. Read more.
India's Q3 GDP Growth Hits 8.4%, FY24 Forecast Raised
India's economy grew at a stellar 8.4% in Q3 FY24, the fastest in six quarters. The government revised its full-year growth estimate upward to 7.6%. Discover the key drivers and what this means for Asia's third-largest economy.
Pharma Chemical Firms Outperform with 7% Growth
Speciality chemical makers supplying pharma CDMOs post 7% sales growth, outpacing non-pharma peers. Strong margins and global shifts fuel this resilient sector. Read more.
Sudeep Pharma Shares Jump 33% After Strong IPO Listing
Sudeep Pharma shares surged 33.78% in market debut, exceeding expectations. Analysts advise partial profit booking while maintaining long-term optimism. Read expert views on buy/sell strategy.
Sudeep Pharma IPO Lists at 23% Premium on NSE, BSE
Sudeep Pharma shares surged 23% in stock market debut today, outperforming grey market expectations. The ₹895-crore IPO was subscribed 93.71 times. Read full analysis.
Sudeep Pharma IPO Lists on BSE, NSE Today
Sudeep Pharma makes its stock market debut today. With a GMP of ₹121, the IPO is set for 20% listing gains after a blockbuster 93.72 times subscription. Get all the live details.
Sudeep Pharma IPO Allotment Today: Check Status Now
Sudeep Pharma IPO allotment likely on November 26. Learn how to check allotment status via BSE, NSE, registrar. Strong 93.72x subscription signals investor confidence.
Aurobindo Pharma China Facility Targets Break-Even by FY26
Aurobindo Pharma's China facility currently faces $1M loss but aims for break-even by Q3-Q4 FY26. CFO outlines growth drivers including Pen-G ramp-up and biosimilar commercialization.
AVP Infracon H1 Revenue Jumps 79%, Profit Rises 82%
AVP Infracon Limited reports stellar H1 FY2024 performance with 79% revenue growth and 82% net profit increase. Strong order book signals continued expansion in infrastructure sector.
Microsoft India Profit Jumps 38.66% in FY25
Microsoft India reports impressive 38.66% profit growth reaching ₹1,245.18 crore in FY2025. Revenue surges 28% to ₹29,303 crore. Discover the key factors behind this stellar performance.
Remedium Lifecare Q2 Profit Jumps 92% to ₹38.62 Cr
Remedium Lifecare reports stellar Q2 results with profit nearly doubling to ₹38.62 crore. Revenue surges 22% driven by strong pharmaceutical exports and domestic growth.
NIS Management H1 FY26: EBITDA Up 11%, Net Profit Rises 13%
NIS Management Limited delivers robust H1 FY26 performance with consolidated EBITDA growing 11% and net profit increasing 13%. Strong financial results showcase company's growth trajectory.
European Pharma Stocks Rebound from AI Shift
European weight-loss drug makers surge as investors rotate capital from expensive AI stocks into healthcare. Zealand Pharma leads with a 20% weekly jump. Explore the market dynamics.
Lincoln Pharma Aims for Rs 1000 Crore Revenue
Lincoln Pharmaceuticals Ltd announces ambitious plan to achieve Rs 1000 crore revenue within three years through strategic expansion and new product launches. Read more about their growth strategy.
Gujarat Pharma Factory Blast: 2 Dead, 20 Injured
Tragic boiler explosion at pharmaceutical factory in Gujarat's Bharuch district claims 2 lives, leaves 20 injured. Massive fire brought under control by emergency teams.
Juspay Turns Profitable with ₹62 Cr PAT in FY25
Juspay Technologies reports ₹62 crore profit after tax and record ₹514 crore revenue in FY25, driven by 300 million daily transactions and global expansion. Read the complete turnaround story.
India's Drug Regulator Tightens Pharma Quality Control
India's DCGI orders nationwide inspections of small pharma units as WHO flags toxic cough syrups. MSMEs struggle to meet new Schedule M compliance deadline of January 2026.
Hindustan Copper Q2 profit jumps 85% to ₹186 crore
State-owned Hindustan Copper reports impressive 85% surge in Q2 FY26 net profit reaching ₹186.02 crore, driven by robust income growth. Discover the key financial highlights and operational insights.
String Metaverse Q2 FY26: Revenue Up 213.49%, Profit 229.12%
String Metaverse Ltd reports explosive Q2 FY26 growth with 213.49% revenue surge and 229.12% profit increase. Discover how the metaverse company achieved these remarkable results.
Indian Pharma Units Face Closure Over GMP Non-Compliance
DCGI directs state authorities to enforce strict GMP compliance by December 31, 2025. Delhi, Himachal Pradesh, Uttarakhand already taking action against non-compliant manufacturers.
DCGI Orders Global Pharma Standards Implementation by Jan 2026
India's drug regulator DCGI mandates global manufacturing standards for all pharma companies by January 2026. State regulators ordered to begin inspections immediately. Read about the strict compliance requirements.
Page 1 of 4